← Back to Screener
Definitive Healthcare Corp. Class A Common Stock (DH)
Price$1.05
Favorite Metrics
Price vs S&P 500 (26W)-70.55%
Price vs S&P 500 (4W)-4.89%
Market Capitalization$154.24M
All Metrics
P/CF (Annual)2.87x
Book Value / Share (Quarterly)$1.97
P/TBV (Annual)12.09x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)2.74%
Cash Flow / Share (Quarterly)$0.26
Price vs S&P 500 (YTD)-65.01%
Gross Margin (TTM)75.88%
Net Profit Margin (TTM)-57.52%
EPS (TTM)$-1.25
10-Day Avg Trading Volume0.22M
EPS Excl Extra (TTM)$-1.25
Revenue Growth (5Y)15.34%
EPS (Annual)$-1.30
ROI (Annual)-31.15%
Gross Margin (Annual)75.88%
Net Profit Margin (5Y Avg)-67.26%
Cash / Share (Quarterly)$1.27
Revenue Growth QoQ (YoY)-1.21%
ROA (Last FY)-18.89%
Revenue Growth TTM (YoY)-4.24%
EBITD / Share (TTM)$-1.59
ROE (5Y Avg)-34.52%
Operating Margin (TTM)-93.07%
Cash Flow / Share (Annual)$0.26
P/B Ratio0.55x
P/B Ratio (Quarterly)1.45x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)0.64x
Net Interest Coverage (TTM)-47.25x
ROA (TTM)-18.10%
EV / EBITDA (TTM)323.84x
EPS Incl Extra (Annual)$-1.30
Current Ratio (Annual)1.64x
Quick Ratio (Quarterly)1.57x
3-Month Avg Trading Volume0.43M
52-Week Price Return-57.81%
EV / Free Cash Flow (Annual)4.19x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.24
P/S Ratio (Annual)0.64x
Asset Turnover (Annual)0.33x
52-Week High$4.70
Operating Margin (5Y Avg)-109.65%
EPS Excl Extra (Annual)$-1.30
CapEx CAGR (5Y)64.22%
26-Week Price Return-66.56%
Quick Ratio (Annual)1.57x
13-Week Price Return-57.48%
Total Debt / Equity (Annual)0.59x
Current Ratio (Quarterly)1.64x
Enterprise Value$155.444
Revenue / Share Growth (5Y)23.22%
Asset Turnover (TTM)0.31x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-86.64%
Cash / Share (Annual)$1.27
3-Month Return Std Dev76.47%
Gross Margin (5Y Avg)78.33%
Net Income / Employee (TTM)$-0
ROE (Last FY)-49.42%
Net Interest Coverage (Annual)-47.25x
EPS Basic Excl Extra (Annual)$-1.30
P/FCF (TTM)3.98x
Receivables Turnover (TTM)4.59x
EV / Free Cash Flow (TTM)4.19x
Total Debt / Equity (Quarterly)0.59x
EPS Incl Extra (TTM)$-1.25
Receivables Turnover (Annual)4.59x
ROI (TTM)-29.81%
P/S Ratio (TTM)0.64x
Pretax Margin (5Y Avg)-103.42%
Revenue / Share (Annual)$2.26
Tangible BV / Share (Annual)$0.24
Forward P/E6.26x
Free OCF CAGR (5Y)11.17%
Price vs S&P 500 (52W)-87.64%
Year-to-Date Return-62.37%
5-Day Price Return11.28%
EPS Normalized (Annual)$-1.30
ROA (5Y Avg)-14.14%
Net Profit Margin (Annual)-57.52%
Month-to-Date Return-12.20%
Cash Flow / Share (TTM)$-1.99
EBITD / Share (Annual)$-1.59
Operating Margin (Annual)-93.07%
LT Debt / Equity (Annual)0.56x
P/CF (TTM)2.87x
ROI (5Y Avg)-22.90%
LT Debt / Equity (Quarterly)0.56x
EPS Basic Excl Extra (TTM)$-1.25
P/TBV (Quarterly)12.09x
P/B Ratio (Annual)1.45x
Pretax Margin (TTM)-86.64%
Book Value / Share (Annual)$1.97
Price vs S&P 500 (13W)-58.17%
Beta1.48x
P/FCF (Annual)4.16x
Revenue / Share (TTM)$2.34
ROE (TTM)-46.61%
52-Week Low$0.92
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.71
3.75
3.75
3.75
Industry Peers — Software(207)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
DHDefinitive Healthcare Corp. Class A Common Stock | 0.64x | -4.24% | 75.88% | -93.07% | $1.05 |
MSFTMicrosoft Corp | 10.15x | 16.67% | 68.59% | 46.62% | $420.26 |
ORCLOracle Corp | 8.04x | 14.87% | 67.08% | 30.56% | $178.34 |
PLTRPalantir Technologies Inc. Class A Common Stock | 75.96x | 56.18% | 82.37% | 31.59% | $142.76 |
SAPSAP SE | 4.65x | 7.67% | 73.62% | 26.71% | $177.41 |
CRMSalesforce, Inc. | 4.00x | 9.58% | 77.68% | 19.34% | $181.22 |
SHOPShopify Inc. Class A subordinate voting shares | 14.33x | 30.14% | 48.07% | 12.70% | $126.94 |
INTUIntuit Inc | 5.48x | 17.21% | 80.05% | 27.08% | $387.11 |
CRWDCrowdStrike Holdings, Inc. Class A Common Stock | 22.04x | 21.71% | 74.81% | -6.10% | $418.20 |
ADBEAdobe Inc. | 4.04x | 10.96% | 89.40% | 36.65% | $248.16 |
NOWSERVICENOW, INC. | 7.42x | 20.88% | 77.56% | 13.74% | $96.44 |
About
Definitive Healthcare provides SaaS-based commercial intelligence and analytics for the U.S. healthcare industry. Its platform enables healthcare organizations and vendors to make data-driven strategic decisions, including market entry planning, sales targeting, and competitive positioning. The company generates revenue primarily through subscription fees for platform access and support services. It operates substantially in the U.S. healthcare market.